英国国家内镜数据库:FIT用于有症状结肠镜分诊的真实世界表现
基于英国国家内镜数据库2023年6月至2025年8月447109例有症状结肠镜的前瞻性分析,FIT记录于202219例(45.2%)。总体癌症检出率1.9%(95%CI 1.8-1.9),FIT≥10为3.8%(95%CI 3.7-3.9),FIT<10为0.3%(95%CI 0.2-0.3)。FIT、年龄和IDA联合模型可检出>94%的癌症并减少>40%的结肠镜需求。
要点
- FIT≥10癌症检出率3.8%,包括40-49岁人群2.5%
- FIT<10癌症检出率仅0.3%,风险极低
- IDA较直肠出血癌症风险更高(aOR 2.2)
核心结论
- FIT为基础的分诊优于症状为基础转诊,FIT≥10识别高危患者包括40-49岁人群,FIT<10提示极低风险。
研究设计与样本
- 英国国家内镜数据库全国性分析,前瞻性收集2023年6月至2025年8月结肠镜报告。
- 共分析447109例有症状结肠镜,其中202219例(45.2%)记录FIT。
- 采用混合效应逻辑回归估计调整比值比(aOR),纳入年龄、性别、症状组和FIT,并用后估计边际模型模拟癌症检出率。
主要发现
- 总体癌症检出率1.9%(95%CI 1.8-1.9)。
- FIT≥10癌症检出率3.8%(95%CI 3.7-3.9),其中40-49岁为2.5%(95%CI 2.3-2.7),16-39岁为0.6%(95%CI 0.5-0.7)。
- FIT<10癌症检出率0.3%(95%CI 0.2-0.3)。
- FIT浓度与癌症风险呈强分级关联,与大息肉关联较弱,与小息肉关联极小。
- IDA较直肠出血癌症风险更高(aOR 2.2,95%CI 2.0-2.3;p<0.01)。
临床怎么用
- 对有症状结肠镜转诊患者,采用FIT分诊可优先识别高危人群。
- FIT≥10尤其合并IDA或年龄40-49岁者应优先安排结肠镜。
- FIT<10且非高龄IDA患者癌症风险极低,可考虑减少或延迟结肠镜。
局限性
- FIT仅在45.2%的有症状结肠镜中记录,可能存在选择偏倚。
- 为观察性数据库分析,无法完全排除混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The UK has adopted faecal immunochemical testing (FIT) to triage symptomatic colonoscopy referrals. OBJECTIVE: Quantify diagnostic yield and independent effects of FIT, age, sex and symptoms on polyp and cancer detection in symptomatic colonoscopy. DESIGN: Nationwide analysis of prospectively collected colonoscopy reports (June 2023-August 2025) from the National Endoscopy Database. Symptomatic procedures, including iron-deficiency anaemia (IDA), were identified and diagnostic yields calculated. Mixed-effects logistic regression estimated adjusted odds ratios (aORs) with age, sex, symptom group and FIT. Post-estimation margins modelled cancer yield by age, FIT and symptoms. RESULTS: Analysis of 447,109 symptomatic colonoscopies, with FIT recorded in 202,219 (45.2%). Overall cancer yield was 1.9% (95% CI, 1.8-1.9). Cancer yield was 3.8% (95% CI, 3.7-3.9) in FIT ≥ 10, including 2.5% (95% CI, 2.3-2.7) at age 40-49 and 0.6% (95% CI, 0.5-0.7) at age 16-39; yield in FIT < 10 was 0.3% (95% CI, 0.2-0.3). FIT concentration showed a strong, graded association with cancer risk, weaker association with large polyps, and minimal association with small polyps. IDA was associated with higher cancer risk versus rectal bleeding (aOR 2.2, 95% CI, 2.0-2.3; p < 0.01). With FIT < 10, cancer yield exceeded 1% only in IDA patients aged > 80 and remained < 0.5% otherwise. A model combining FIT, age, and IDA detected > 94% of cancers while reducing colonoscopy demand by > 40%. CONCLUSION: This national analysis demonstrates the superiority of FIT-based triage over symptom-based referral, with FIT ≥ 10 identifying high-risk patients, including those aged 40-49, while FIT < 10 indicated very low risk.
引用
- Beaton D, Mohamed M, Sharp L, et al. Real-World Performance of FIT Triage for Symptomatic Colonoscopy: Analysis of the UK National Endoscopy Database (NED). Aliment Pharmacol Ther. 2026. PMID: 41601400. doi:10.1111/apt.70537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。